Elevated asymmetric dimethylarginine (ADMA) parallel to small dense LDL levels in coronary artery disease

被引：0
|
作者：
Cakir, E
Ozcan, O
Yaman, H
Akgul, EO
Ozkan, M
Bilgi, C
Erbil, MK
机构：
来源：
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY | 2005年 / 38卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
196
引用
收藏
页码：878 / 878
页数：1
相关论文
共 50 条
  • [1] Elevated levels of asymmetric dimethylarginine (ADMA) as a marker of cardiovascular disease and mortality
    Böger, RH
    Maas, R
    Schulze, F
    Schwedhelm, E
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2005, 43 (10) : 1124 - 1129
  • [2] Independent association of asymmetric dimethylarginine (ADMA) with presence and severity of coronary artery disease
    Fard, A
    Pinney, SP
    Vest, JA
    Di Tullio, MR
    Berglund, L
    Ginsberg, HN
    Rabbani, LE
    Schwartz, A
    Cannon, P
    Homma, S
    CIRCULATION, 2000, 102 (18) : 757 - 757
  • [3] Effect of chronic elevated asymmetric dimethylarginine (ADMA) levels on granulopoiesis
    Gernot Beutel
    Ronny Perthel
    Mayuren Suntharalingam
    Stefanie M. Bode-Böger
    Jens Martens-Lobenhoffer
    Jan T. Kielstein
    Heike Kielstein
    Annals of Hematology, 2013, 92 : 505 - 508
  • [4] Effect of chronic elevated asymmetric dimethylarginine (ADMA) levels on granulopoiesis
    Beutel, Gernot
    Perthel, Ronny
    Suntharalingam, Mayuren
    Bode-Boeger, Stefanie M.
    Martens-Lobenhoffer, Jens
    Kielstein, Jan T.
    Kielstein, Heike
    ANNALS OF HEMATOLOGY, 2013, 92 (04) : 505 - 508
  • [5] Elevated plasma level of asymmetric dimethylarginine (ADMA) is associated with coronary artery disease independent of the traditional atherosclerotic risk factors
    Vest, JA
    Fard, A
    Suleski, M
    Sciacca, R
    Prieto, AFJ
    Berglund, L
    Bryant, TA
    Kazanowski, MA
    Magnano, AR
    Cardinale, C
    DiTullio, MR
    Cannon, PJ
    Schwartz, A
    Rabbani, LE
    Homma, S
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 35 (02) : 243A - 243A
  • [6] Urinary asymmetric dimethylarginine (ADMA) is a predictor of mortality risk in patients with coronary artery disease
    Wolf, Christian
    Lorenzen, Johan M.
    Stein, Sylvia
    Tsikas, Dimitrios
    Stoerk, Stefan
    Weidemann, Frank
    Ertl, Georg
    Anker, Stefan D.
    Bauersachs, Johann
    Thum, Thomas
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2012, 156 (03) : 289 - 294
  • [7] Aortic stenosis is associated with elevated plasma levels of asymmetric dimethylarginine (ADMA)
    Ngo, Doan T. M.
    Heresztyn, Tamila
    Mishra, Kumaril
    Marwick, Thomas H.
    Horowitz, John D.
    NITRIC OXIDE-BIOLOGY AND CHEMISTRY, 2007, 16 (02): : 197 - 201
  • [8] Aortic stenosis is associated with elevated plasma levels of asymmetric dimethylarginine (ADMA)
    Ngo, DT
    Heresztyn, T
    Mishra, K
    Marwick, T
    Horowitz, J
    CIRCULATION, 2005, 112 (17) : U753 - U753
  • [9] The response of asymmetric dimethylarginine (ADMA) levels to stent placement in patients with coronary heart disease
    Nemeth, A.
    Ajtay, Z.
    Cziraki, A.
    Horvath, I
    Papp, L.
    Sulyok, E.
    Scalera, F.
    Lobenhoffer, J. M.
    Awiszus, F.
    Bode-Boeger, S. M.
    ACTA PHYSIOLOGICA HUNGARICA, 2010, 97 (01) : 126 - 127
  • [10] Asymmetric dimethylarginine (ADMA) levels correlate with the angiographic extent of coronary artery disease in patients with stable angina and/or abnormal stress test
    Ioakeimidis, N.
    Vlachopoulos, C.
    Terentes-Printzios, D.
    Baou, K.
    Antoniou, G.
    Xaplanteris, P.
    Lazaros, G.
    Roussakis, G.
    Aggeli, C.
    Stefanadis, C.
    EUROPEAN HEART JOURNAL, 2009, 30 : 188 - 189
12345